Who owns the STENDRA (AVANAFIL) TABLETS trademark?

The STENDRA (AVANAFIL) TABLETS trademark is owned by Metuchen Pharmaceuticals LLC.

What class is the STENDRA (AVANAFIL) TABLETS trademark registered in?

The STENDRA (AVANAFIL) TABLETS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for STENDRA (AVANAFIL) TABLETS?

The USPTO serial number for STENDRA (AVANAFIL) TABLETS is 87376446.

What is the registration number for STENDRA (AVANAFIL) TABLETS?

STENDRA (AVANAFIL) TABLETS is registered under USPTO registration number 0.

STE

USPTO Trademark Record

ABANDONED

STENDRA (AVANAFIL) TABLETS

SN 87376446·Reg 0·Filed Mar 18, 2017

Owner Metuchen Pharmaceuticals LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

STENDRA (AVANAFIL) TABLETS (Serial No. 87376446), Registration No. 0, is a abandoned US trademark filed on Mar 18, 2017 by Metuchen Pharmaceuticals LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

STENDRA (AVANAFIL) TABLETS (Reg. #0) is an abandoned US trademark that was filed in 2017 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 18, 2017

SERIAL

87376446

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Metuchen Pharmaceuticals LLC

Entity

LLC

State

Address

1st floor, 11 Commerce Drive, Cranford, NJ, 07016

Country

Attorney

NameMark Pohl

Law firm

MARK POHL PHARMACEUTICAL PATENT ATTORNEYS, LLC

Docket

Metuchen

Address

55 MADISON AVENUE, 4TH FLOOR, MARK POHL (P4014), MORRISTOWN, NJ 07960, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateMar 18, 2017

Serial Number87376446

Registration No.0

Registration DateDec 31, 1969

Status DateJan 29, 2019

Published for OppositionSep 05, 2017

Mark TypeDesign with words

Attorney DocketMetuchen

Status DescriptionDead and abandoned due to failure to respond

Filing Signals

FILED

2017

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Mar 25, 2018

First use in commerce: Mar 25, 2018

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

35 events

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

Jan 30, 2019

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

Jan 29, 2019

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 03, 2018

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION E-MAILED

Jul 03, 2018

NON-FINAL ACTION E-MAILED

SU - NON-FINAL ACTION - WRITTEN

Jul 03, 2018

SU - NON-FINAL ACTION - WRITTEN

STATEMENT OF USE PROCESSING COMPLETE

Apr 12, 2018

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 12, 2018

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS STATEMENT OF USE RECEIVED

Mar 25, 2018

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Mar 25, 2018

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 31, 2017

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 05, 2017

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 05, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 16, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 24, 2017

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 24, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINER'S AMENDMENT ENTERED

Jul 24, 2017

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT -WRITTEN

Jul 24, 2017

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jul 24, 2017

EXAMINERS AMENDMENT E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jul 22, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 22, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 22, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 28, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 28, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 28, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 27, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 27, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 27, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

Jun 23, 2017

EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Jun 23, 2017

EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

Jun 23, 2017

NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

Jun 23, 2017

COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY

ASSIGNED TO EXAMINER

Jun 12, 2017

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

Mar 24, 2017

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 23, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 22, 2017

NEW APPLICATION ENTERED

STENDRA (AVANAFIL) TABLETS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Metuchen Pharmaceuticals LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Mark Pohl

Resources

Company